Magnesium sulfate Alternatives Compared
| Magnesium sulfate | Lamictal (lamotrigine) | Lamotrigine |
|
|---|
| Magnesium sulfate | Lamictal (lamotrigine) | Lamotrigine |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription and OTC
Prescribed for Hypomagnesemia, Ventricular Arrhythmia, Seizure Prevention, Barium Poisoning. Magnesium sulfate may also be used for purposes not listed in this medication guide. |
Prescription only
Lamictal is used to decrease the frequency and severity of seizures in some types of epilepsy and also to stabilize mood in bipolar I disorder. It is an oral tablet that is taken once or twice a day... View more |
Prescription only
Lamotrigine is used to decrease the frequency and severity of seizures in some types of epilepsy and also to stabilize mood in bipolar I disorder. It is an oral tablet that is taken once or twice a... View more |
Related suggestions Seizure Prevention (Seizure Prophylaxis)
|
|||||||||||||||||||||||
| More about Magnesium sulfate | More about Lamictal (lamotrigine) | More about Lamotrigine | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Magnesium sulfate has an average rating of 7.0 out of 10 from a total of 6 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 33% reported a negative effect. |
Lamictal has an average rating of 8.0 out of 10 from a total of 797 ratings on Drugs.com. 76% of reviewers reported a positive effect, while 13% reported a negative effect. |
Lamotrigine has an average rating of 7.8 out of 10 from a total of 1848 ratings on Drugs.com. 73% of reviewers reported a positive effect, while 15% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Magnesium sulfate side effects |
View all Lamictal side effects |
View all Lamotrigine side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
Lower cost generic |
|||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Magnesium sulfate prices |
View all Lamictal prices |
View all Lamotrigine prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Epsom Salt | Other lamotrigine brands include: Lamictal CD, Lamictal ODT, Lamictal XR, Subvenite | Lamictal, Lamictal CD, Lamictal ODT, Lamictal XR, Subvenite | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
N/A |
25.7 hours |
25.7 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 106 drugs are known to interact with Magnesium sulfate:
|
A total of 287 drugs are known to interact with Lamictal:
|
A total of 287 drugs are known to interact with Lamotrigine:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
N/A |
December 27, 1994 |
December 27, 1994 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.